Table of Contents Author Guidelines Submit a Manuscript
International Journal of Reproductive Medicine
Volume 2018 (2018), Article ID 3597487, 10 pages
https://doi.org/10.1155/2018/3597487
Research Article

Early Implanon Discontinuation and Associated Factors among Implanon User Women in Debre Tabor Town, Public Health Facilities, Northwest Ethiopia, 2016

Midwifery Department, College of Medicine and Health Sciences, University of Gondar, P.O. Box 196, Gondar, Ethiopia

Correspondence should be addressed to Mengstu Melkamu Asaye; moc.liamg@mutsgnem

Received 8 August 2017; Accepted 7 December 2017; Published 21 January 2018

Academic Editor: Robert Gaspar

Copyright © 2018 Mengstu Melkamu Asaye et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. Mahumud, G. Hossain, A. R. Sarkar et al., “Prevalence and associated factors of contraceptive discontinuation and switching among Bangladeshi married women of reproductive age,” Open Access Journal of Contraception, vol. 6, no. 7, 2015. View at Google Scholar
  2. S. Staveteig, L. Mallick, and R. Winter, “Uptake and discontinuation of long-acting reversible contraceptives (Larcs) in low-income countries,” Dhs Analytical Studies, vol. 54, pp. 17–77, 2015. View at Google Scholar
  3. WHO, “Research Policy Brief. Contraception: discontinuation and switching in developing countries,” in Reproductive Health Matters, vol. 12, Department of Reproductive Health and Research, 15 edition, 2012. View at Google Scholar
  4. S. Gebremedhin, “Trend and socio-demographic differentials of Caesarean section rate in Addis Ababa, Ethiopia: Analysis based on Ethiopia demographic and health surveys data,” Reproductive Health, vol. 11, no. 1, article no. 14, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Asnake, E. G. Henry, Y. Tilahun, and E. Oliveras, “Addressing unmet need for long-acting family planning in Ethiopia: Uptake of single-rod progestogen contraceptive implants (Implanon) and characteristics of users,” International Journal of Gynecology and Obstetrics, vol. 123, no. 1, pp. e29–e32, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. S. A. Yalew, B. M. Zeleke, and A. S. Teferra, “Demand for long acting contraceptive methods and associated factors among family planning service users, Northwest Ethiopia: A health facility based cross sectional study,” BMC Research Notes, vol. 8, no. 1, article no. 974, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. USAID, “Reducing discontinuation of contraceptive use and unmet need for family planning: policy options,” Jordan Population and Family Health Surveys (JPFHS), 2007-2009. View at Google Scholar
  8. W. J. Van den Bosch, “The progestagen-containing implant (Implanon); who is responsible for what,” Jornal of contraceptive in Netherlands, vol. 148, no. 36, pp. 1758–1760, 2009. View at Google Scholar
  9. M. Lori, P. Dickerson, A. Vanessa, M. Diaz, C. Svetlana, and B. Kristin, “Early removal and side effects asssociated with long acting reversible contraception,” Family Medicine, vol. 45, no. 10, pp. 701–707, 2013. View at Google Scholar
  10. N. H. Madugu, M. A. Abdul, U. Bawa, and B. Kolawole, “Uptake of hormonal implants contraceptive in Zaria, Northern Nigeria,” Open Journal of Obstetrics and Gynecology, vol. 5, no. 5, 2015. View at Google Scholar
  11. K. Birhane, S. Hagos, and M. Fantahun, “Early discontinuation of implanon and its associated factors among women who ever used implanon in Ofla District, Tigray, Northern Ethiopia,” International Journal of Pharma Sciences and Research, vol. 6, no. 3, 8 pages, 2015. View at Google Scholar
  12. A. M. Teunissen, B. Grimm, and F. J. M. E. Roumen, “Continuation rates of the subdermal contraceptive Implanon and associated influencing factors,” The European Journal of Contraception & Reproductive Health Care, vol. 19, no. 1, pp. 15–21, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Burusie, “Reasons for premature removal of implanon among users in arsi zone,” Reproductive System & Sexual Disorders, vol. 4, no. 1, p. 6, 2015. View at Google Scholar
  14. P. M. Casey, M. E. Long, M. L. Marnach, and J. E. Bury, “Bleeding related to etonogestrel subdermal implant in a US population,” Contraception, vol. 83, no. 5, pp. 426–430, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Harvey, C. Seib, and J. Lucke, “Continuation rates and reasons for removal among Implanon® users accessing two family planning clinics in Queensland, Australia,” Contraception, vol. 80, no. 6, pp. 527–532, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. O. Balogun, N. Olaomo, A. Adeniran, and A. Fawole, “Implanon sub-dermal implant: an emerging method of contraception in Ilorin, Nigeria,” Journal of Medical and Biomedical Science, vol. 3, no. 1, pp. 1–5, 2014. View at Publisher · View at Google Scholar
  17. J. D. Ojule and E. O. Oranu, “Experience with implanon in Southern Nigeria,” Jornal of Medicine and Medical Science, vol. 3, no. 11, 5 pages, 2012. View at Google Scholar
  18. J. T. Mutihir and D. D. Nyango, “Indications for removal of etonogestrel implant within two years of use in Jos, Nigeria,” East African Medical Journal, vol. 87, no. 11, 4 pages, 2010. View at Google Scholar · View at Scopus
  19. D. Grunloh, T. Casner, G. Secura, J. Peipert, and T. Madden, “Early discontinuation of long-acting reversible contraception,” Contraception, vol. 88, no. 3, pp. 433–473, 2013. View at Publisher · View at Google Scholar
  20. M. Isley, “Implanon: the subdermal contraceptive implant.,” Journal of Pediatric & Adolescent Gynecology, vol. 23, no. 6, pp. 364–367, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Kamhawi, C. Underwood, H. Murad, and B. Jabre, “Client-centered counseling improves client satisfaction with family planning visits: evidence from Irbid, Jordan,” Global Health: Science and Practice Journal, vol. 1, no. 2, pp. 180–192, 2013. View at Publisher · View at Google Scholar
  22. C. I. Duvan, E. Gözdemir, I. Kaygusuz, Z. Kamalak, and N. Ö. Turhan, “Etonogestrel contraceptive implant (implanon): Analysis of patient compliance and adverse effects in the breastfeeding period,” Journal of the Turkish German Gynecology Association, vol. 11, no. 3, pp. 141–144, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. S. RamaRao, M. Lacuesta, M. Costello, B. Pangolibay, and H. Jones, “The link between quality of care and contraceptive use,” International Family Planning Perspectives, vol. 29, no. 2, pp. 76–83, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Bhatia, S. Nangia, S. Aggarwal, and C. Tewari, “Implanon: Subdermal single rod contraceptive implant,” The Journal of Obstetrics and Gynecology of India, vol. 61, no. 4, pp. 422–425, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. Ethiopia. CSA. Housing and Population Census of Ethiopia 2007.